Last Price
Where today's price sits in its 52-week range
Renata PLC ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটি মোটামুটি অবস্থায় আছে (আমাদের বিশ্লেষণে 100-এর মধ্যে 53)। কোম্পানিটি লাভ করছে, তবে গত বছরের তুলনায় মুনাফা কিছুটা কমেছে। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক কম। কোম্পানিটি কিছুটা ডিভিডেন্ড দেয় (বছরে প্রায় 1.2%)।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Wait & Watch
Watch listAverage company, very little trading
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Priced about fairly — neither a bargain nor expensive.
P/E Ratio
23.8
Price per ৳1 of yearly earnings
Dividend Yield
1.20%
Annual cash return on the price
P/B Ratio
1.5
Price per ৳1 of net assets
Trading at 23.8 — below its 5-year average of 32.6.
The raw figures behind the verdict — for the curious.
EPS
৳19.36
Earnings per share (latest year)
P/E Ratio
25.2
Price you pay per ৳1 of earnings
Dividend Yield
1.20%
Annual cash return on the price
Reserve & Surplus
৳3,391 Cr
Company's accumulated savings
Total Loan
৳1,888 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Made a profit every year for 5 years.
Earnings Per Share
Profit you earn per share
Profitable per share every year for 5 years.
Yearly Cash Dividend
% of face value
📢 New 55% dividend just declared — record 17 Nov 2025
Paid a dividend every year for 5 years running.
The deeper numbers — revenue, margins, debt and cash quality over the years.
What the share price has been doing over the last week.
Up 1.0% in the past week, on lighter-than-usual trading.
Past week
+1.0%
Price move over 7 days
Vs market
+0.3%
Ahead/behind the DSEX index
Trading volume
0.6×
vs its normal volume
Up days
5/7
Green days this week
52-week spot
54%
Position in 1-year range
Trades around ৳2.0 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
RENATA scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| RENATA | 53 | ৳461 | +0.2% | 23.8 | +1.2% | +10.7% |
Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2025.
Worth watching — foreign investors cut their stake from 19.9% to 18.3% since Jun 2025. Keep an eye on why.
Owners (sponsors) hold 51% — heavily invested in the company's success.
Recent news and announcements about this company.